NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-168-2011-0-AT-10 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology AT EP 12741191.6 Issued
NCI E-168-2011-0-BG-12 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology BG EP 12741191.6 Issued
NCI E-168-2011-0-CA-04 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology CA National Stage 2842180 Issued
NCI E-168-2011-0-AU-03 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology AU National Stage 2012284122 Issued
NCI E-168-2011-0-PCT-02 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology PCT PCT PCT/US2012/047069 Expired
NCI E-174-2008-0-US-08 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma US DIV 13/551,580 Abandoned
NIAID E-253-2011-1-US-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US 61/672,708 Abandoned
NCI E-157-2012-0-US-01 Nitric Oxide-Releasing Diazeniumdiolated Polyvinylpyrrolidone-Based Polymers, And Compositions, Medical Devices, And Uses Thereof US 61/672,486 Abandoned
NCI E-201-2006-1-US-03 Compositions And Methods For Diagnosis And Treatment of Tumors US DIV 13/549,633 8568977 Abandoned PDF
NCI E-073-2014-0-US-01 Azaindenoisoquinoline Topoisomerase I Inhibitors US ORD 13/548,579 8686146 Issued PDF
NCI E-172-2011-0-PCT-02 IDENTIFICATION OF GENETIC BACKGROUND-INDEPENDENT EARLY NONINVASIVE BIOMARKERS FOR ALCOHOLIC LIVER DISEASE USING URINARY METABOLOMICS AND THE PPARA-NULL MOUSE PCT PCT PCT/US2012/46705 Expired
NINDS E-301-2007-0-JP-14 Summation Of TMS Stimulation Through Several Coils JP DIV 2012-268579 Issued
NCI E-070-2005-0-US-05 Inhibitor Of Ubiquitin E1 US DIV 13/547,417 Abandoned
NIAAA E-210-2012-0-US-01 Intralipid As A Contrast Agent To Enhance Subsurface Blood Flow Imaging US 61/670,954 Abandoned
NCI E-227-2006-5-US-06 Prevention Of Tissue Ischemia And Related Methods US DIV 13/546,931 8865672 Issued PDF
NCI E-227-2006-5-US-07 Prevention of Tissue Ischemia And Related Compositions US DIV 13/546,941 8557788 Issued PDF
NIDDK E-234-2011-2-IN-03 Conjugating Amines IN National Stage 168/DELNP/2014 Pending
NIDDK E-234-2011-2-PCT-01 Conjugating Amines PCT PCT COMB PCT/US12/046196 Expired
NINDS E-101-2012-0-US-01 DEUTERATED DROXIDOPA DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS US 61/669,772 Abandoned
NCI E-086-2010-0-US-03 Immune Modulators Relating To FOXO3A US National Stage 13/520,904 Abandoned
NCI E-194-2000-0-US-05 Viral Chemokine-Antigen Fusion Proteins US DIV 13/541,997 8460675 Abandoned PDF
NIAID E-216-2011-0-US-01 USE OF INTERLEUKIN-7 ANTAGONISTS FOR TREATMENT OF HIV INFECTIONS US 61/667,748 Abandoned
NIAID E-018-2010-0-US-08 Recombinant Modified Vaccinia Ankara (MVA) Vaccinia Virus Containing Restructured Insertion Sites US National Stage 13/502,205 9133480 Issued PDF
NIAID E-219-2014-0-PCT-02 Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase PCT PCT PCT/US2012/044962 Expired
NHGRI E-209-2011-0-PCT-02 ACSF3 Mutations In Metabolic Disorders PCT PCT PCT/US12/44926 Expired
NHLBI E-253-2009-0-US-04 COMPOSITE PROBES AND USE THEREOF IN SUPER RESOLUTION METHODS US National Stage 13/519,737 8547533 Issued PDF
NHGRI E-116-2011-0-EP-03 Method Of Treating Pathologic Heterotopic Ossification EP National Stage 12735389.4 Abandoned
NHGRI E-116-2011-0-PCT-02 Method Of Treating Pathologic Heterotopic Ossification PCT PCT PCT/US12/044613 Expired
NCI E-205-2010-2-CA-02 Photosensitizing Antibody-Flurophore Conjugates CA National Stage 2841120 Issued
NCI E-205-2010-2-EP-04 Photosensitizing Antibody-Flurophore Conjugates EP National Stage 12738664.7 Issued
NCI E-205-2010-2-DE-14 Photosensitizing Antibody-Flurophore Conjugates DE EP 12738664.7 Issued
NCI E-205-2010-2-FR-16 Photosensitizing Antibody-Flurophore Conjugates FR EP 12738664.7 Issued
NCI E-205-2010-2-IT-18 Photosensitizing Antibody-Flurophore Conjugates IT EP 12738664.7 Issued
NCI E-205-2010-2-CH-13 Photosensitizing Antibody-Flurophore Conjugates CH EP 12738664.7 Issued
NCI E-205-2010-2-GB-17 Photosensitizing Antibody-Flurophore Conjugates GB EP 12738664.7 Issued
NCI E-205-2010-2-ES-15 Photosensitizing Antibody-Flurophore Conjugates ES EP 12738664.7 Issued
NCI E-205-2010-2-JP-06 Photosensitizing Antibody-Flurophore Conjugates JP National Stage 2014-520202 Issued
NCI E-205-2010-2-PCT-01 Photosensitizing Antibody-Flurophore Conjugates PCT PCT COMB PCT/US2012/044421 Expired
NCI E-205-2010-2-CN-11 Photosensitizing Antibody-Flurophore Conjugates CN DIV 201710729452.7 Abandoned
NCI E-205-2010-2-CN-03 Photosensitizing Antibody-Flurophore Conjugates CN National Stage 201280043973.2 Pending
NCI E-205-2010-2-IN-05 Photosensitizing Antibody-Flurophore Conjugates IN National Stage 267/DELNP/2014 Abandoned
NCI E-185-2008-0-US-03 HMGN Polypeptides As Immune Enhancers And HMGN Antagonists As Immune Suppressants US CON 13/533,492 9567566 Issued PDF
NIAID E-225-2012-0-US-01 A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL
A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL TISSUE-SPECIFIC EXPRESSION 		US 61/664,518 Abandoned
NCI E-269-2009-0-US-10 Pseudomonas Exotoxin A With Reduced Immunogenicity US National Stage 13/395,422 8936792 Issued PDF
NIDDK E-049-2010-2-US-03 Methanocarba Adenosine Derivatives, Pharmaceutical Compositions, and Method of Reducing Intraocular Pressure US National Stage 13/512,681 8518957 Abandoned PDF
NCI E-272-1998-0-US-06 NEW TUMOR SUPPRESSOR GENE P33ING2 US DIV 13/530,070 Abandoned
NCI E-022-2010-0-US-04 Modulated Programmed Death Ligand-1 US National Stage 13/509,476 Abandoned
NIAID E-293-2011-1-US-01 Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine US 61/661,209 Abandoned
NINDS E-088-2012-0-US-01 Methods And Compositions For Identifying JC Virus US 61/661,289 Abandoned
NCI E-015-2011-0-CA-04 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer CA National Stage 2839301 Issued